Full Text View
Tabular View
No Study Results Posted
Related Studies
Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
This study is ongoing, but not recruiting participants.
Study NCT00070148   Information provided by National Cancer Institute (NCI)
First Received: October 3, 2003   Last Updated: August 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Weight Changes
Additional conditions recognized in this trial
Body Weight
Body Weight Changes
Weight Loss
More general conditions related to this trial
Signs and Symptoms
Interventions listed in this trial
megestrol acetate
oxandrolone
quality-of-life assessment
Additional drug interventions recognized in this trial
Megestrol
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Appetite Stimulants
Central Nervous System Agents
Central Nervous System Stimulants
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Wake Forest University
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services